Shanghai Rendu Biotechnology Co., Ltd.

688193

CNE1000059K5

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 23/05/2024 BST			5-day change	1st Jan Change
31.06 ^CNY	-3.93%		-8.27%	-31.16%

04-29	Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-02	Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.	CI

Shanghai Rendu Biotechnology Co., Ltd.(SHSE:688193) added to Shanghai Stock Exchange Composite Index

March 30, 2023 at 05:00 am

Shanghai Rendu Biotechnology Co., Ltd Added to Shanghai Stock Exchange Composite Index.

Latest news about Shanghai Rendu Biotechnology Co., Ltd.

Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.	04-01	CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-27	CI
Shanghai Rendu Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	02-19	CI
Shanghai Rendu Biotechnology Co., Ltd. authorizes a Buyback Plan.	02-17	CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	31/07/23	CI
Shanghai Rendu Biotechnology Gets Certificate for Registration of HIV Kit	21/06/23	MT
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Shanghai Rendu Biotechnology Co., Ltd.(SHSE:688193) added to Shanghai Stock Exchange Composite Index	30/03/23	CI
Shanghai Rendu Biotechnology Co., Ltd.(SHSE:688193) added to Shanghai Stock Exchange A Share Index	30/03/23	CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23	CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22	CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	12/08/22	CI
Coland Holdings Limited cancelled the acquisition of an unknown stake in Shanghai Rendu Biotechnology Co., Ltd.	24/01/14	CI
Coland Holdings Limited agreed to acquire an unknown stake in Shanghai Rendu Biotechnology Co., Ltd. for TWD 180 million.	25/01/13	CI

Chart Shanghai Rendu Biotechnology Co., Ltd.

Duration

Period

Chart Shanghai Rendu Biotechnology Co., Ltd.

More charts

Shanghai Rendu Biotechnology Co Ltd is a China-based company mainly engaged in the research, development and sales of molecular diagnostic reagents. The Company utilizes ribonucleic acid (RNA) isothermal amplification technology to provides multiple series of diagnostic reagents, including respiration series, reproduction series, enterovirus series, blood-borne diseases series and other diagnostic reagents. The Company also designs and manufactures medical instruments. The Company mainly sells its products within domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SHANGHAI RENDU BIOTECHNOLOGY CO., LTD.	-31.16%	179M
ABBOTT LABORATORIES	-5.56%	181B
MEDTRONIC PLC	-0.11%	108B
BECTON, DICKINSON AND COMPANY	-6.17%	66.57B
DEXCOM, INC.	+2.64%	49.95B
CENCORA, INC.	+6.58%	43.84B
HOYA CORPORATION	+4.91%	41.71B
METTLER-TOLEDO INTERNATIONAL, INC.	+21.98%	31.59B
TERUMO CORPORATION	+14.45%	25.3B
WEST PHARMACEUTICAL SERVICES, INC.	-5.81%	23.94B